180
Participants
Start Date
December 1, 2018
Primary Completion Date
December 31, 2019
Study Completion Date
May 31, 2020
GamTBvac vaccine
introduction of GamTBvac (lyophilisate for preparation of solution for subcutaneous administration, 5.35 mg / dose) twice into a shoulder with an 8-week interval.
placebo
introduction of placebo twice into a shoulder with an 8-week interval.
"City polyclinic № 2 Of the Department of health of the city of Moscow, Выделите текст, чтобы посмотреть примеры", Moscow
Sechenov University, Moscow
contract research organization Cromos Pharma
UNKNOWN
contract research organization K-Research
UNKNOWN
Gamaleya Research Institute of Epidemiology and Microbiology, Health Ministry of the Russian Federation
OTHER